Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Nov;38(4):385-95.
doi: 10.1017/S0033583506004240. Epub 2006 Jul 3.

Designing ligands to bind proteins

Affiliations
Review

Designing ligands to bind proteins

George M Whitesides et al. Q Rev Biophys. 2005 Nov.

Abstract

The ability to design drugs (so-called 'rational drug design') has been one of the long-term objectives of chemistry for 50 years. It is an exceptionally difficult problem, and many of its parts lie outside the expertise of chemistry. The much more limited problem - how to design tight-binding ligands (rational ligand design) - would seem to be one that chemistry could solve, but has also proved remarkably recalcitrant. The question is 'Why is it so difficult?' and the answer is 'We still don't entirely know'. This perspective discusses some of the technical issues - potential functions, protein plasticity, enthalpy/entropy compensation, and others - that contribute, and suggests areas where fundamental understanding of protein-ligand interactions falls short of what is needed. It surveys recent technological developments (in particular, isothermal titration calorimetry) that will, hopefully, make now the time for serious progress in this area. It concludes with the calorimetric examination of the association of a series of systematically varied ligands with a model protein. The counterintuitive thermodynamic results observed serve to illustrate that, even in relatively simple systems, understanding protein-ligand association is challenging.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Association of a benzenesulfonamide with tail (shown as wavy line) to carbonic anhydrase. The tail can make favorable contacts with the surface of the protein.
Fig. 2
Fig. 2
Variation in (a) free energy of binding and dissociation constant, (b) enthalpy of binding, and (c) entropy of binding with the number of residues in the tail for benzenesulfonamides with oligoethylene glycol (ArEGnOMe), oligoglycine (ArGlynO), and oligosarcosine (ArSarnO) tails. Linear fits to the data in (b) and (c) are shown. The horizontal dashed line in (c) separates favorable (−TΔS° <0) from unfavorable (−TΔS° >0) entropy of binding. (Reprinted with permission from Krishnamurthy et al. 2006. Copyright 2006 American Chemical Society.)
Fig. 3
Fig. 3
The association of para-substituted benzenesulfonamides with oligoethylene glycol (ArEGnOMe), oligoglycine (ArGlynO), and oligosarcosine (ArSarnO) tails with bovine carbonic anhydrase II. (a) EEC plot for the association. The solid lines are linear fits to the datasets and give values for the compensation (from the slopes) as follows: −0·96±0·08 (ArSarnO), −1·07±0·07 (ArGlynO), and −1·32±0·09 (ArEGnOMe); these observations demonstrate perfect compensation between enthalpy and entropy. The dotted vertical line separates favorable (−TΔS°<0) from unfavorable (−TΔS°>0) entropy of binding. (b) A schematic diagram for the association. This schematic diagram represents the catalytic cleft of the enzyme as a cone with the Zn2+ co-factor at the apex. The bottom surface (shaded) of the cleft is the ‘hydrophobic wall’ of the enzyme. Ellipses depict the residues of the ligand; the sizes of the ellipses are roughly proportional to the mobility of the individual residues. Benzenesulfonamide ligands with one (white), three (light gray), and five (dark gray) residues in the tail are shown. (Modified with permission from Krishnamurthy et al. 2006. Copyright 2006 American Chemical Society.)

References

    1. Benkovic SJ, Hammes-Schiffer S. A perspective on enzyme catalysis. Science. 2003;301:1196–1202. - PubMed
    1. Boriack PA, Christianson DW, Kingery-Wood J, Whitesides GM. Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence binding constants. Journal of Medicinal Chemistry. 1995;38:2286–2291. - PubMed
    1. Cappalonga Bunn AM, Alexander RS, Christianson DW. Mapping protein-peptide affinity: binding of peptidylsulfonamide inhibitors to human carbonic anhydrase II. Journal of the American Chemical Society. 1994;116:5063–5068.
    1. Carlson HA. Protein flexibility and drug design: how to hit a moving target. Current Opinion in Chemical Biology. 2002;6:447–452. - PubMed
    1. Chandler D. Two faces of water. Nature. 2002;417:491. - PubMed

Publication types